Abstract
In the International Classification of Diseases (ICD‑10), the diagnosis of chronic pain is not presented, which makes it difficult to conduct accurate epidemiological studies and prevents the development of an adequate diagnosis and multimodal therapy strategy. ICD‑11 will be the first version to include chronic pain as a diagnosis. According to the new concept, chronic pain is a real disease associated with multiple changes in the nervous, endocrine and immune systems. Developing a comprehensive treatment plan is of paramount importance and requires a multimodal plan that includes non‑drug and pharmacotherapeutic strategies for pain management. One of the promising areas of pharmacotherapy is the use of complex therapy regimens: meloxicam (Amelotex) – tolperisone (Calmirex) – B vitamins (compliments B).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
